Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Patent issued for Neoprobe's RIGS/ACT anticancer technology

Oct. 7, 1998

Genentech's Herceptin given FDA approval

Sep. 28, 1998

Enzon's PEG-Intron A advances to phase III trials for malignant melanoma

Sep. 24, 1998

Procyon receives Japanese patent for prostate cancer treatment

Sep. 24, 1998

Theratope cancer vaccine study fulfills enrollment

Sep. 23, 1998

Immune Response treats first patient in phase Ib colon cancer trial

Sep. 23, 1998

Endorex receives Japanese patent for ImmTher

Sep. 23, 1998

Cell Genesys announces positive phase I/II results using GVAX vaccine for prostate cancer

Sep. 22, 1998

IL-4(38-37)-PE38KDEL treatment results in complete regression of human glioblastoma tumors

Sep. 21, 1998

York Medical's DiaCIM will be administered to cancer patients

Sep. 18, 1998

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...